admission date:  [2114-12-24]              discharge date:   [2115-1-6]date of birth:  [2070-12-17]             sex:   mservice: medicineallergies:heparin agentsattending:[first name3 (lf) 943]chief complaint:hypotension with elevated lactate, code sepsis.major surgical or invasive procedure:right internal jugular venous catheter placement.history of present illness:44 yom pmh esrd secondary to brights disease on hd s/p twofailed renal transplants, hcv, chf with ef 20%, af on coumadinwho presented to the ed with a two week history of diffuseabdominal pain with one day of nausea and vomiting [2114-12-24]. twoweeks prior to admission the patient began to experience diffusedull abdominal pain without nausea or vomiting and loose stools2-3 times per day. the patient believed this was secondary tofluid overload. one week prior to presentation the patientcomplained of subjective fevers, cough productive of yellowsputum. his nephrologist gave him a five-day course ofazithromycin. the patient had persistent symptoms and wasstarted on levofloxacin by his pcp two days prior to admission.the patient had a history of tylenol use 3g/day for 5 days priorto admission for fever, body aches. the day prior to admissionthe patient began to experience worsened abdominal painassociated with nausea, a few episodes of vomiting,nonbilious/nonbloody, and diarrhea 4-5 times per day, watery,nonbloody..in the ed the patient was found to be hypotensive with lactateof 5.6 and a code sepsis was called. he was given vanco, flagyland zosyn for presumed infection. he was given decadron forpresumed adrenal insufficiency. he was also given calciumgluconate, sodium bicarbonate, insulin and d50 for hyperkalemia.a cvl was placed and he received 3l of ns with normalization ofpressures. he was transferred to the micu..in the micu the patient's lfts were significantly elevated andpeaked at alt 3016, ast 2956, ldh [2064], inr 4.3 on [12-25]. thiswas thought to be secondary to shock liver in the setting ofhypotension/sepsis versus tylenol toxicity despite negativeserum tylenol. lfts subsequently trending down..upon transfer to the floor, the patient continues to complain ofcough productive of yellow sputum. denies chest pain, shortnessof breath. the patient denied any fevers/chills, abdominal pain,nausea, vomiting. diarrhea improving. denies dysuria/hematuria;minimal urine output while on hd. denies lightheadedness. deniesmyalgias/arthralgias. review of systems otherwise negative indetail.past medical history:1. end-stage renal disease secondary to glomerulonephritis onhemodialysis status post two failed transplants [2089] and [2097]2. coronary artery disease status post myocardial infarction andstent [2105]3. congestive heart failure with ejection fraction 10%, statuspost right sided placement of icd4. cerebrovascular accident [2105] without residual complicationsor deficits5. atrial fibrillation6. hypertension7. basal cell and squamous cell skin cancers status postexcision and radiation to lower face8. gout9. erectile dysfunction10. right lung pneumonia with pleurisy11. hepatitis c, genotype 2social history:he is married, lives in [location 13011] with wife of 11 years, son anddaughter. [name (ni) ] owns and runs a landscaping/contracting businessand works for the city sanding the streets during the winter. hedenies tobacco or recreational drug use.family history:mother, maternal uncle, and grandfather with [name2 (ni) ]grandmother, lymphoma in paternal grandfather, peripheralvascular disease in maternal grandmother, no h/o kidney disease,other ca, heart disease, cva, or psychiatric diseases.physical exam:vital signs: 98.6 112/68 130 18 98rageneral: nad, pleasant and cooperative.heent: perrl, eomi, op clear, mmm, anicteric scleraeneck: no masses, no lad, no jvd, no carotid bruit, rij in placeheart: irreg irreg, nl s1s2, holosystolic murmur [3-5] overprecordium, laterally displaced pmi, no rublungs: cta b/l, no crackles or wheezes.abdomen: soft, nd, +bs, no organomegaly, tender in rlq, negative[doctor last name ] sign, no rebound, no guardingextremities: no cyanosis, no clubbing; no edema, 1+ dp, pulsesb/l.neurologic: awake, alert, a&ox3, cn ii-xii intact; strength 5/5bilaterally, sensory and coordination grossly intact, reflesxes1+ bilaterallyskin: petechia on trunk, av fistula in l arm, positive thrillpertinent results:labwork on admission:[2114-12-24] 12:15pm   wbc-14.0# rbc-3.54 hgb-11.5 hct-34.7mcv-98 mch-32.5 mchc-33.2 rdw-14.6[2114-12-24] 12:15pm   plt count-286[2114-12-24] 12:15pm   neuts-77.9 lymphs-14.1 monos-6.7 eos-0.2basos-1.1[2114-12-24] 12:15pm   pt-23.1 ptt-29.9 inr(pt)-2.3[2114-12-24] 12:15pm   glucose-62 urea n-90 creat-14.8#sodium-139 potassium-7.1 chloride-86 total co2-23 aniongap-37[2114-12-24] 12:15pm   alt(sgpt)-1122 ast(sgot)-1469 ld(ldh)-1523alk phos-156 amylase-59 tot bili-1.5[2114-12-24] 12:15pm   lipase-43[2114-12-24] 12:15pm   albumin-4.0 calcium-10.7 phosphate-11.2#magnesium-2.8[2114-12-24] 12:15pm   cortisol-36.0[2114-12-24] 12:27pm   lactate-5.9.chest (pa & lat)  [2114-12-24]impression:clear lungs, mild pulmonary congestion and cardiomegaly,unchanged..ct abd w&w/o c  [2114-12-25]impression:1) cardiomegaly and hepatomegaly with abnormal liver perfusionlikely secondary to passive congestion (nutmeg liver). no focalhepatic abscess or adjacent hematoma.2) cholelithiasis and sludge/vicarious excretion of iv contrast.small amount of pericholecystic fluid is present. the fluidcould be due to patient's liver dysfunction/third spacing fromchf. if cholecystitis is of clinical concern, hida scan can beperformed provided the total bilirubin is not elevated.3) hyperdense renal cortex in left lower quadrant transplantedkidney. findings are most likely due to chronic rejection orprior atn. there is apparent thickening of the arterial wallsupplying the transplant. no hydronephrosis or perinephriccollection.4) minor anatomic variant involving liver vasculature asdescribed above. hepatic veins and portal venous system appearwidely patent.5) 6 mm lesion in head of pancreas. continued follow up of thisarea is recommended on future studies.6) areas of ground glass opacity and intralobular septalthickening in the lung bases, most likely due to fluidoverload/chf. nodular areas of opacity are also present whichcould be due to infection. continued followup is reccomended.7) small lymph nodes and vague retroperitoneal stranding.findings could be due to chf..ecg study date of [2114-12-25]  2:41:34 amatrial fibrillation with rapid ventricular responseintraventricular conduction delay - possible atypical leftbundle branch blockanterior myocardial infarct, age indeterminate - may be oldnonspecific st-t wave changessince previous tracing of [2114-2-7], ventricular rate faster.echo study date of [2114-12-28]conclusions:1. the left atrium is moderately dilated.2. the left ventricular cavity is severely dilated. there issevere global left ventricular hypokinesis. overall leftventricular systolic function is severely depressed. leftventricular dysnchrony is present.3. the right ventricular cavity is dilated. right ventricularsystolicfunction appears depressed.4. the aortic valve leaflets are mildly thickened. mild (1+)aorticregurgitation is seen.5. the mitral valve leaflets are mildly thickened. moderate tosevere (3+) mitral regurgitation is seen. the effectiveregurgitant orifice is >=0.40cm26. moderate [2+] tricuspid regurgitation is seen. there ismoderate pulmonary artery systolic hypertension.7. there is a trivial/physiologic pericardial effusion.8. compared with the report of the prior study of [2114-1-8], lvfunction is probably worse..chest (pa & lat)  [2114-12-29]impression: evidence for pulmonary venous hypertension.cardiomegaly. no focal consolidation..labwork on discharge:[2115-1-6] 06:30amcomplete blood countwhite blood cells 8.7 k/ul 4.0 - 11.0red blood cells 2.74 m/ul 4.6 - 6.2hemoglobin 9.7 g/dl 14.0 - 18.0hematocrit 29.3 % 40 - 52mcv 107 fl 82 - 98mch 35.6 pg 27 - 32mchc 33.3 % 31 - 35rdw 18.1 % 10.5 - 15.5basic coagulation (pt, ptt, plt, inr)platelet count 128 k/ul 150 - 440[2115-1-6] 06:30amrenal & glucoseglucose 121 mg/dl 70 - 105urea nitrogen 56 mg/dl 6 - 20creatinine 7.5# mg/dl 0.5 - 1.2sodium 138 meq/l 133 - 145potassium 3.8 meq/l 3.3 - 5.1chloride 99 meq/l 96 - 108bicarbonate 27 meq/l 22 - 32anion gap 16 meq/l 8 - 20enzymes & bilirubinalanine aminotransferase (alt) 146 iu/l 0 - 40asparate aminotransferase (ast) 45 iu/l 0 - 40lactate dehydrogenase (ld) 274 iu/l 94 - 250alkaline phosphatase 151 iu/l 39 - 117bilirubin, total 1.6 mg/dl 0 - 1.5chemistryalbumin 3.1 g/dl 3.4 - 4.8calcium, total 7.4 mg/dl 8.4 - 10.2phosphate 4.1 mg/dl 2.7 - 4.5magnesium 2.2 mg/dl 1.6 - 2.6[2115-1-6] 06:30amrenal & glucoseglucose 121 mg/dl 70 - 105urea nitrogen 56 mg/dl 6 - 20creatinine 7.5# mg/dl 0.5 - 1.2sodium 138 meq/l 133 - 145potassium 3.8 meq/l 3.3 - 5.1chloride 99 meq/l 96 - 108bicarbonate 27 meq/l 22 - 32anion gap 16 meq/l 8 - 20enzymes & bilirubinalanine aminotransferase (alt) 146 iu/l 0 - 40asparate aminotransferase (ast) 45 iu/l 0 - 40lactate dehydrogenase (ld) 274 iu/l 94 - 250alkaline phosphatase 151 iu/l 39 - 117bilirubin, total 1.6 mg/dl 0 - 1.5chemistryalbumin 3.1 g/dl 3.4 - 4.8calcium, total 7.4 mg/dl 8.4 - 10.2phosphate 4.1 mg/dl 2.7 - 4.5magnesium 2.2 mg/dl 1.6 - 2.6[2115-1-6] 10:29ambasic coagulation (pt, ptt, plt, inr)pt 27.9 sec 10.4 - 13.1ptt 47.7 sec 22.0 - 35.0inr(pt) 2.9   0.9 - 1.1brief hospital course:44 year-old male with past medical history of esrd on hd, hcv,presenting with hypotension and elevated lactate, presumedsepsis without source found. the patient was noted to haveelevated lfts on admission. the patient was found to be hit abpositive..1. sepsis: there was no source found, but patient had receivedantibiotics prior to admission. the patient remained afebrileand hemodynamically stable throughout transfer to the floor. thepatient had leukocytosis on admission but this resolved prior totransfer. the patient completed an empiric seven-day course ofvancomycin/zosyn and ten-day course of flagyl. the patient'simmunosuppressive therapy with cyclosporine for history of renaltransplant was discontinued; prednisone 10 mg qod was continued.cxr x 2 without evidence of pneumonia. the patient's blood,urine, stools, and sputum cultures were negative at the time ofdischarge. c. difficile toxin b was negative. the patientcomplained of continued cough and loose stools which wereimproving prior to discharge..2. hypotension: resolved prior to transfer to the floor. likelysepsis given elevated lactate. hypovolemia possible in settingof poor po prior to admission. cardiac etiology unlikely; nosignificant change in cardiac function and cardiac enzymesunrevealing. adrenal insufficiency was unlikely with randomcortisol of 36,  however, the patient on chronic steroids; thepatient was continued on prednisone 10 mg every other day forhistory of renal transplant. the patient received treatment forsepsis as above..3. elevated lfts/coagulopathy: secondary to shock liver versustylenol toxicity. the patient was initially maintained onmucomyst gtt but this was discontinued when the patient's liverfunction tests improved. there was likely a component ofcongestion secondary to chf. this was unlikely secondary to hcvas there was no change in immunosuppression and only mild activeinflammation on very recent biopsy. unlikely to be due to recentliver biopsy. the patient's liver function tests continued totrend down prior to discharge..4. atrial fibrillation: the patient's coumadin was initiallyheld in the setting of liver failure and elevated inr. thepatient's digoxin and amiodarone were initially held in thesetting of renal and liver failure and the patient's rate wassubsequently poorly-controlled to heart rate 130-140s. thepatient was followed by his primary cardiologist, dr. [last name (stitle) 911],during admission. the patient's amiodarone was restarted andincreased from previous per his recommendations. digoxin was notrestarted. the patient's elanopril was discontinued on admissionand the patient was started on captopril; there was an attemptto up-titrate the dose but the patient's blood pressure did nottolerate the increase. the patient was discharged on captopril6.25 twice daily. the patient's blood pressure does not toleratebeta-blocker therapy. the patient was restarted on coumadinprior to discharge. the patient's rapid ventricular rate is mostlikely compensatory for low ejection fraction; rate control to110-120s is acceptable. the patient's rate was at goal 110s-120son discharge. the patient will follow-up with dr. [last name (stitle) 911] as anoutpatient..5. acute on chronic renal failure: baseline creatinine [5-2]. thepatient is on hd status post two failed renal transplants. thedifferential for the patient's acute renal failure includedacute tubular necrosis and cyclotoxicity (recently onazithromycin). the patient's ace inhibitor was initially held.the patient's creatinine did not improve to baseline and was 7.5prior to discharge. the patient was followed by the renalservice throughout hospitalization. the patient continued toreceive hemodialysis per his mwf schedule. the patient wasstarted on sensipar for elevated pth. the patient was continuedon prednisone 10 mg qod for history of renal transplant. thepatient's cyclosporine was discontinued. amphogel wasdiscontinued and cinecalcet was added to the patient's regimen..6. thrombocytopenia/hit ab positive: hit antibodies were sentbecause of the patient's thrombocytopenia. the patient's hitantibodies were positive. the patient had been on heparin sc andheparin flushes in the micu but these were discontinued prior totransfer to the floor. the patient was followed by hematologyduring admission. the patient had a right basilic veinthrombosis visualized but no other signs or symptoms ofthrombosis. after discussion with hematology and pharmacy, thepatient was started on argatroban and bridged to coumadin. thepatient's inr goal was 2.5-3.5 given his history of liverdisease..7. congestive heart failure. ef of 10% per echo [12-28] with 3+ mr,2+ tr. mixed ischemic/nonischemic dilated cardiomyopathy.patient has a fixed lad/anterior defect on mibi on 2/[2114]. thepatient is status post icd placement [1-1]. the patient wasstarted on captopril as above. the patient's blood pressure doesnot tolerate beta-blocker therapy. the patient's volume statuswas addressed at hemodialysis. the patient was assessed forbiventricular icd by ep; the decision was made not to place atthis time given the patient's narrow qrs duration and especiallyin the setting of recent sepsis. the patient will follow-up withdrs. [last name (stitle) 911] and [name5 (ptitle) 437] in [5-3] weeks. the patient will receiveoutpatient cardiopulmonary assessment for possible cardiactransplant..8. coronary artery disease status post myocardial infarction andstent [2105]. the patient was without complaints of chest painthroughout admission. the patient was continued on aspirin. thepatient's elanopril was discontinued and the patient was startedon captopril as above. the patient's blood pressure does nottolerate beta-blocker therapy..9. nucleated red blood cells. there were 20 nrbc/100 white bloodcells on the patient's blood smear on transfer to the floor,with low grade hemolysis and high reticulocyte count. hematologywas consulted and believed this was likely secondary tohyperactive marrow stimulated in the setting of recent sepsis.this resolved prior to discharge.medications on admission:prednisone 10 mg po qodb complex-vitamin c-folic acid 1 mg po dailyaspirin 81 mg tablet po dailycoumadin 1 mg po dailyamiodarone 100 mg [hospital1 ]cyclosporineamphogelelanoprildischarge medications:1. captopril 12.5 mg tablet sig: 0.5 tablet po bid (2 times aday).disp:30 tablet(s) refills:22. prednisone 10 mg tablet sig: one (1) tablet po qod ().3. b complex-vitamin c-folic acid 1 mg capsule sig: one (1) cappo daily (daily).4. aspirin 81 mg tablet, chewable sig: one (1) tablet, chewablepo daily (daily).5. cinacalcet 30 mg tablet sig: one (1) tablet po daily (daily).disp:30 tablet(s) refills:26. amiodarone 200 mg tablet sig: one (1) tablet po daily(daily).disp:30 tablet(s) refills:27. lanthanum 500 mg tablet, chewable sig: one (1) tablet,chewable po tid w/meals (3 times a day with meals).disp:90 tablet, chewable(s) refills:28. pantoprazole 40 mg tablet, delayed release (e.c.) sig: one(1) tablet, delayed release (e.c.) po q24h (every 24 hours).disp:30 tablet, delayed release (e.c.)(s) refills:29. coumadin 1 mg tablet sig: two (2) tablet po at bedtime.disp:60 tablet(s) refills:210. oxycodone 5 mg tablet sig: one (1) tablet po q8h (every 8hours) as needed for abdominal pain.disp:20 tablet(s) refills:0discharge disposition:homedischarge diagnosis:primary:1. sepsis2. shock liver3. heparin-induced thrombocytopenia.secondary:1. end-stage renal disease on hemodialysis2. coronary artery disease status post myocardial infarction andstent [2105]3. congestive heart failure with ejection fraction 10%, statuspost right sided placement of icd4. cerebrovascular accident [2105] without residual complicationsor deficits5. atrial fibrillation6. hypertension7. basal cell and squamous cell skin cancers status postexcision and radiation to lower face8. gout9. erectile dysfunction10. right lung pneumonia with pleurisy11. hepatitis c, genotype 2discharge condition:afebrile, vital signs stable.discharge instructions:please contact a physician if you experience fevers, chills,abdominal pain, nausea, vomiting, diarhea, black stools or bloodin your stools, or any other concerning symptoms..please take your medications as prescribed.- you cyclosporine was discontinued for now; you will restart atoutpatient dialysis per dr. [last name (stitle) 1860].- your amphogel was discontinued.- your elanopril was discontined.- you should take captopril 6.25 mg twice daily to control yourheart rate.- your amiodarone was increased to 200 mg once daily.- you should take fosrenal 500 mg three times daily with mealsto control phosphorus because of kidney failure.- you should take cinecalcet 30 mg once daily to control calciumand phosphorus because of kidney failure.- you should take protonix 40 mg once daily to protect yourstomach when taking prednisone.- you should take coumadin 2 mg once daily and follow-up incoumadin clinic on monday..please keep your appointments as below.followup instructions:please follow-up in coumadin clinic on monday regarding your inrlevels..the office of drs. [last name (stitle) 911] and [name5 (ptitle) 437] should contact you regardingfollow-up appointments. please contact dr.[name (ni) 5786] office at([telephone/fax (1) 7236] or dr.[name (ni) 3536] office at ([telephone/fax (1) 13786] if you donot hear from their representatives or have any questions..follow-up with your nephrologist: provider: [first name8 (namepattern2) ] [name11 (nameis) ], [name initial (nameis) ].d.,ph.d.[md number(3) 708]:[telephone/fax (1) 435] date/time:[2115-1-7] 2:00.[month/day/year ] test for heart transplant evaluation: provider: [name10 (nameis) 10081]testing phone:[telephone/fax (1) 1566] date/time:[2115-1-14] 1:15.follow-up with your primary care doctor, dr. [last name (stitle) 14757] [name (stitle) 13674], on[1-17] at 5:30pm. please call [telephone/fax (1) 14758] if you need toreschedule..provider:  [name10 (nameis) 676] clinic phone:[telephone/fax (1) 59] date/time:[2115-4-16]3:30provider: [known firstname ] [last name (namepattern4) 1008], m.d. phone:[telephone/fax (1) 285]date/time:[2115-4-16] 4:00